Surgical Therapy of Cutaneous Melanoma

Seminars in Oncology

Volumn 34, Issue 3, 2007, Pages 270-280

  Blazer III, Dan G ^a   Sondak, Vernon K ^b   Sabel, Michael S ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; AXILLARY LYMPH NODE; BRAIN METASTASIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CUTANEOUS MELANOMA; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; MELANOMA; MORBIDITY; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; SKIN METASTASIS; SOFT TISSUE METASTASIS; SPINAL CORD METASTASIS; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ALGORITHMS; HUMANS; LYMPH NODE EXCISION; MELANOMA; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 34249889853     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.03.007     Document Type: Article

References (70)

1. Jemal A., Seigel R., Ward E., et al. Cancer Statistics, 2006. CA Cancer J Clin 56 8 (2006) 106-130
2. Aloia T.A., and Gershenwald J.E. Management of early-stage cutaneous melanoma. Curr Probl Surg 42 (2005) 460-534
3. Chang A.E., Johnson T.M., and Rees R. Cutaneous neoplasms. In: Greenfield L.J., Mulholland M.W., Oldham K.T., et al. (Eds). Surgery: Scientific Principles and Practice (1997), Lippincott-Raven, Philadelphia 2231-2246
4. Essner R. Surgical treatment of malignant melanoma. Surg Clin North Am 83 (2003) 109-156
5. Veronesi U., and Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg 126 (1991) 438-441
6. Karakousis C.P., Balch C.M., Urist M.M., et al. Local recurrence in malignant melanoma: Long-term results of the multi-institutional randomized surgical trial. Ann Surg Oncol 3 (1996) 446-452
7. Balch C.M., Soong S.-J., Ross M.I., et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Ann Surg Oncol 7 (2000) 87-97
8. Cohn-Cedermark G., Rutqvist L.E., Andersson R., et al. Long term results of a randomized study by the Swedish Melanoma Group on 2cm vs 5cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0mm. Cancer 89 (2000) 1495-1501
9. Khayat D., Rixe O., Martin G., et al. Surgical margins in cutaneous melanoma (2cm versus 5cm for lesions measuring less than 2.1mm thick). Cancer 97 (2003) 1941-1946
10. Thomas J.M., Newton-Bishop J., A'Hern R., et al. Excision margins in high-risk malignant melanoma. N Engl J Med 350 (2004) 757-766
11. Olsen G. Some views on the treatment of melanomas of the skin. Arch Chirurg Neerl 22 (1970) 79-90
12. Kennedy D.E., Brown B.W., and McBride C.M. Excision of underlying fascia with a primary malignant melanoma: Effect on recurrence and survival rates. Surgery 92 (1982) 615-618
13. Cassileth B.R., Lusk E.J., and Tenaglia A.N. Patients' perceptions of the cosmetic impact of melanoma resection. Plast Reconstr Surg 71 (1983) 73-75
14. de Braud F., Khayat D., Kroon B.B., et al. Malignant melanoma. Oncol Hematol 47 (2003) 35-63
15. Nathansohn N., Schachter J., and Gutman H. Patterns of recurrence in patients with melanoma after radical lymph node dissection. Arch Surg 140 (2005) 1172-1177
16. Tyler D.S., Onaitis M., Kherani A., et al. Positron emission tomography scanning in malignant melanoma. Cancer 89 (2000) 1019-1025
17. Acland K.M., O'Doherty M.J., Russell-Jones R., et al. The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma. J Am Acad Dermatol 42 (2000) 606-611
18. Eigtved A., Andersson A.P., Dahlstrom K., et al. Use of flourine-18-flourodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma. J Nucl Med 27 (2000) 70-75
19. Byers R.M. Treatment of the neck in melanoma. Otolaryngol Clin North Am 31 (1986) 833-839
20. O'Brian C.J., Petersen-Schaefer K., Ruark D., et al. Radical, modified and selective neck dissection for cutaneous malignant melanoma. Head Neck 17 (1995) 232-241
21. Van de Vrie W., Eggermont A.M.M., Van Putten W.L., et al. Therapeutic lymphadenectomy in melanomas of the head and neck. Head Neck 15 (1993) 377-381
22. Karakousis C.P., Hena M.A., Emrich L.J., et al. Axillary node dissection in malignant melanoma: Results and complications. Surgery 108 (1990) 10-17
23. Wrightson W.R., Wong S.L., Edwards M.J., et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 10 (2003) 676-680
24. Lawton G., Rasque H., and Ariyan S. Preservation of muscle fascia to decrease lymphedema after complete axillary and ilioinguinofemoral lymphadenectomy for melanoma. J Am College Surg 191 (2002) 16-23
25. Shen P., Conforti A.M., Essner R., et al. Is the node of Cloquet the sentinel node for the iliac/obturator node group?. Cancer 6 (2000) 93-97
26. Kretschmer L., Neumann C., Preusser K.P., et al. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin: An analysis of survival and local recurrence. Acta Oncol 40 (2001) 72-78
27. Mann G.B., and Coit D.G. Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes?. Ann Surg Oncol 6 (1999) 263-271
28. Coit D.G., Peters M., and Brennan M.F. A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. Arch Surg 126 (1991) 1366-1372
29. Karakousis C.P., Driscoll D.L., Rose B., et al. Groin dissection in malignant melanoma. Ann Surg Oncol 1 (1994) 271-277
30. Karakousis C.P., Emrich L.J., Driscoll D.L., et al. Survival after groin dissection for malignant melanoma. Surgery 109 (1991) 119-126
31. Kissin M.W., Simpson D.A., Easton D., et al. Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma. Br J Surg 74 (1987) 1023-1026
32. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
33. Balch C.M., Cascinelli N., and Milton G.W. Elective node dissection: Pros and cons. In: Balch C.M., and Milton G.W. (Eds). Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide (1985), Lippincott, Philadelphia 131-157
34. Balch C.M. The role of elective lymph node dissection in melanoma: rationale, results and controversies. J Clin Oncol 6 (1988) 163-172
35. Veronesi U., Adamus J., Bandiera D.C., et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49 (1982) 2420-2430
36. Balch C.M., Soong S.-J., Bartolucci A.A., et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224 (1996) 255-266
37. Cascinelli N., Morabito A., Santinami M., et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial. Lancet 351 (1998) 793-796
38. Sim F.H., Taylor W.F., Pritchard D.J., et al. Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study. Mayo Clin Proc 61 (1986) 697-705
39. Morton D.L., Thompson J.F., Essner R., et al., Multicenter Selective Lymphadenectomy Trial Group. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Ann Surg 230 (1999) 453-463
40. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patters of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16 (1998) 2253-2260
41. Vuylsteke R.J.C.L.M., van Leeuwen P.A.M., Muller M.G.S., et al. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: Long-term follow-up results. J Clin Oncol 21 (2003) 1057-1065
42. Thompson J.F., McCarthy W.H., Bosch C.M., et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 5 (1995) 255-260
43. Sondak V.K., Taylor J.M.G., Sabel M.S., et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11 (2004) 247-258
44. Bleicher R.J., Essner R., Foshag L.J., et al. Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 21 (2003) 1326-1331
45. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinal-node biopsy or nodal observation in melanoma. N Engl J Med 355 (2006) 1307-1371
46. Sabel M.S., Griffith K.A., Sondak V.K., et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 201 (2005) 37-47
47. Wagner J.D., Gordon M.S., Chuang T.Y., et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 89 (2000) 453-462
48. McMasters K.M., Wong S.L., Edwards M.J., et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 9 (2002) 137-141
49. Eggermont A.M.M., van Geel A.N., de Wilt J.H., et al. The role of isolated limb perfusion for melanoma confined to the extremities. Surg Clin North Am 83 (2003) 371-384
50. Singletary S.E., Tucker S.L., and Boddie A.W. Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma. Cancer 61 (1988) 1437-1440
51. Fraker D.L. Management of in-transit melanoma of the extremity with isolated limb perfusion. Curr Treat Options Oncol 5 (2004) 173-184
52. Si Z., Hersey P., and Coates A.S. Clinical responses and lymphoid infiltrates in metastatic melanoma following treatment with intralesional GM-CSF. Melanoma Res 6 (1996) 247-255
53. Thompson J.F., and Kam P.C. Isolated limb infusion for melanoma: A simple but effective alternative to isolated limb perfusion. J Surg Oncol 88 (2004) 1-3
54. Thompson J.F., Kam P.C., Waugh R.C., et al. Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol 14 (1998) 238-247
55. Harpole D.H., Johnson C.M., Wolfe W.G., et al. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 103 (1992) 743-748
56. Gorenstein L.A., Putnam J.B., ANatarajan G., et al. Improved survival after resection of pulmonary metastses from malignant melanoma. Ann Thorac Surg 52 (1991) 204-210
57. Pawlik T.M., Zorzi D., Abdalla E.K., et al. Hepatic resection for metastatic melanoma: Distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 13 (2006) 712-720
58. Ollila D.W., Essner R., Wanek L.A., et al. Surgical Resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 131 (1996) 975-979
59. Klasse J.M., and Kroon B.B. Surgery for melanoma metastatic to the gastrointestinal tract. Br J Surg 77 (1990) 60-61
60. Caputy G.G., Donahue J.H., Goellner J.R., et al. Metastatic melanoma of the gastrointestinal tract. Results of surgical management. Arch Surg 126 (1991) 336-344
61. Ricaniadis N., Konstadoulakis M.M., Walsh D., et al. Gastrointestinal metastases from malignant melanoma. Surg Oncol 4 (1995) 105-110
62. Agrawal S., Yao T.J., and Coit D.G. Surgery for melanoma metastatic to the gastrointestinal tract. Arch Surg 131 (1999) 975-979
63. Markowitz J.S., Cosimi L.A., Carey R.W., et al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg 126 (1991) 703-707
64. Gadd M.A., and Coit D.G. Recurrence patterns and outcome in 1019 patietns undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 127 (1992) 1412-1416
65. Karakousis C.P., Velez A., Driscoll B.A., et al. Metastatectomy in malignant melanoma. Surgery 115 (1995) 295-302
66. Meyer T., Merkel S., Goehl J., et al. Surgical therapy for distant metastases of malignant melanoma. Cancer 89 (2000) 1983-1991
67. Wong J.H., Euhus D.M., and Morton D.L. Surgical resection for metastatic melanoma to the lung. Arch Surg 123 (1988) 1091-1095
68. Tafra L., Dale P.S., Wanek L.A., et al. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg 110 (1995) 119-128
69. La Hei E.R., Thompson J.F., McCaughan B.C., et al. Surgical resection of pulmonary metastatic melanoma: A review of 83 thoracotomies. Asia Pacific Heart J 5 (1996) 111-114
70. Leo F., Cagini L., Rocmans P., et al. Lung metastases from melanoma: When is surgical treatment warranted?. Br J Cancer 83 (2000) 569-557